Reaction Details Report a problem with these data
Target
GTPase KRas
Ligand
BDBM50514405
Substrate
n/a
Meas. Tech.
ChEMBL_1856530 (CHEMBL4357259)
IC50
442±n/a nM
Citation
Lanman, BA; Allen, JR; Allen, JG; Amegadzie, AK; Ashton, KS; Booker, SK; Chen, JJ; Chen, N; Frohn, MJ; Goodman, G; Kopecky, DJ; Liu, L; Lopez, P; Low, JD; Ma, V; Minatti, AE; Nguyen, TT; Nishimura, N; Pickrell, AJ; Reed, AB; Shin, Y; Siegmund, AC; Tamayo, NA; Tegley, CM; Walton, MC; Wang, HL; Wurz, RP; Xue, M; Yang, KC; Achanta, P; Bartberger, MD; Canon, J; Hollis, LS; McCarter, JD; Mohr, C; Rex, K; Saiki, AY; San Miguel, T; Volak, LP; Wang, KH; Whittington, DA; Zech, SG; Lipford, JR; Cee, VJ Discovery of a Covalent Inhibitor of KRAS J Med Chem 63:52-65 (2020) [PubMed] Article
More Info.:
Target
Name:
GTPase KRas
Synonyms:
GTPase KRas, N-terminally processed | K-Ras 2 | KRAS | KRAS2 | Ki-Ras | RASK2 | RASK_HUMAN | c-K-ras | c-Ki-ras
Type:
PROTEIN
Mol. Mass.:
21656.10
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1476955
Residue:
189
Sequence:
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQRVEDAFYTLVREIRQYRLKKISKEEKTPGCVKIKKCIIM
Inhibitor
Name:
BDBM50514405
Synonyms:
CHEMBL4438343
Type:
Small organic molecule
Emp. Form.:
C32H30ClF3N4O2
Mol. Mass.:
595.054
SMILES:
CC(C)c1ccccc1-n1c2cc(c(Cl)cc2c(nc1=O)N1CCN(C[C@@H]1C)C(=O)C=C)-c1ccccc1C(F)(F)F |r,wU:26.30,(14.21,-28.03,;15.55,-28.81,;15.54,-30.35,;16.88,-28.04,;18.22,-28.81,;19.55,-28.04,;19.55,-26.49,;18.22,-25.73,;16.89,-26.49,;15.55,-25.73,;15.55,-24.2,;16.89,-23.42,;16.88,-21.87,;15.55,-21.11,;15.54,-19.57,;14.22,-21.88,;14.22,-23.42,;12.89,-24.19,;12.88,-25.72,;14.21,-26.49,;12.87,-27.25,;11.57,-23.41,;11.57,-21.87,;10.26,-21.1,;8.91,-21.85,;8.9,-23.4,;10.24,-24.19,;10.23,-25.72,;7.58,-21.08,;7.6,-19.54,;6.24,-21.84,;4.91,-21.06,;18.21,-21.1,;18.2,-19.57,;19.53,-18.78,;20.88,-19.55,;20.88,-21.1,;19.55,-21.87,;19.55,-23.4,;18.23,-24.17,;20.88,-24.16,;19.55,-24.93,)|